Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2025-12-25 @ 11:26 PM
NCT ID: NCT01026493
Term: Muscle weakness lower limb
Organ System: Musculoskeletal and connective tissue disorders
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (4.0)
Notes: None
Study: NCT01026493
Study Brief: Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 8 View
EG001 None 0 6 View
EG002 None 0 9 View
EG003 None 1 8 View
EG005 None 0 73 View
EG006 None 0 32 View
EG007 None 0 37 View
EG004 None 0 73 View